Elena Élez

The medical community has long categorized colorectal cancer as a disease of the elderly, typically manifesting after age 50. However, clinical data now show a shift in demographics. Patients aged 35, 40, and 45 are increasingly presenting in hospital wards with tumors that are often already in advanced stages. While lifestyle factors have traditionally been the primary focus of investigation, a new study from Spain suggests that chronic environmental exposure to specific chemical agents may be a primary driver of this trend.

The Picloram Signature in Early-Onset Tumors

Researchers in Spain have identified a biological signature associated with picloram, an herbicide used for decades in agricultural settings, within the colorectal tumors of adults under 50. This research, published in April 2026 in the journal Nature Medicine, marks a significant shift in the understanding of early-onset colorectal cancer.

For years, picloram was regarded as a pesticide with minimal risk to human health. The Spanish team, led by Elena Élez, head of the unit conducting the research, discovered that the molecular presence of the herbicide correlates with the specific clinical and pathological characteristics seen in younger patients. Unlike the slower-progressing tumors often found in older populations, these early-onset cases frequently exhibit more aggressive behavior.

The identification of a molecular signature allows scientists to move beyond general associations and pinpoint a specific chemical agent within the tumor tissue itself. This evidence suggests that the herbicide does not merely correlate with the disease but leaves a detectable trace in the malignant cells of the colon.

Global Trends and the Rise of Younger Patients

The increase in colorectal cancer among adults under 50 is not an isolated phenomenon. The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO), reports that the incidence of these cancers is rising in several dozen countries. This trend is particularly pronounced in North America, Europe, and Australia.

In France, the signals are equally concerning. A 2024 study conducted by Santé publique France revealed a marked progression of the disease among adults born after 1980. The acceleration is so significant that some projections suggest colorectal cancer could become the leading cause of death among young people by 2030.

The geographical distribution of these cases often mirrors areas of high industrial agricultural activity. This has led epidemiologists to focus on chronic environmental exposures. While genetic mutations are more frequent in countries where early cases are rising, the speed of the increase suggests an external trigger rather than a gradual genetic shift in the population.

Environmental Toxins versus Lifestyle Drivers

Before the picloram findings, the medical consensus leaned heavily toward behavioral and biological factors.

• Consumption of ultra-processed foods.
• Rising rates of obesity and sedentary lifestyles.
• Excessive alcohol consumption.
• Disruptions to the intestinal microbiota.

Recent research indicates that the cause may be a combination of these factors and specific toxins. For instance, in April 2025, researchers identified a bacterial toxin called colibactine, present in the human gut, as a potential catalyst for these tumors. The incidence of colorectal cancer in young patients was noted to be increasing in at least 27 countries, with colibactine acting as a possible biological trigger.

The picloram study adds a chemical layer to this biological puzzle. According to a meta-analysis by Xie et al. in 2024, which examined 33 epidemiological studies, pesticide exposure can induce genetic mutations through direct DNA damage. These chemicals can activate oncogenes, inhibit programmed cell death (apoptosis), and alter hormonal regulation, creating an environment conducive to tumor progression.

The Paradox of Safe Pesticides

The picloram findings highlight a recurring issue in regulatory toxicology: the classification of chemicals as safe or non-carcinogenic based on limited or outdated testing. A separate study published in Nature Health established a strong association between exposure to pesticides considered non-carcinogenic and an increased risk of cancer on a national scale. That study reported a risk increase of 150% linked to these supposedly safe substances.

This echoes older concerns raised by institutional bodies. In 2013, the French National Institute of Health and Medical Research (INSERM) published a collective expertise stating there was a strong presumption of a link between pesticide exposure and several malignancies, including prostate cancer and non-Hodgkin lymphomas. While colorectal cancer was not the primary focus of that 2013 report, the current evidence regarding picloram suggests the scope of pesticide-induced malignancy is broader than previously recognized.

The current agricultural model, designed to maximize productivity, often involves the excessive use of herbicides. While chemicals like glyphosate and atrazine have faced intense scrutiny and legal battles, the picloram study suggests that other, less-discussed herbicides may pose an equal or greater threat to younger populations.

As the link between picloram and early-onset colorectal cancer becomes clearer, the focus shifts toward regulatory review and screening. The discovery of a molecular signature provides a tool for clinicians to potentially identify exposed patients and for regulators to re-evaluate the safety profiles of herbicides used in the food chain.

Consult your healthcare provider for screening recommendations or concerns regarding colorectal health.